Skip to main content
Download PDF

Volume 7 Supplement 1

16th International Symposium on HIV and Emerging Infectious Diseases

Cystatin C and cardiovascular risk in HIV infected patients

Retrovirology volume 7, Article number: P62 (2010) Cite this article

Background

HIV infection, combined antiretroviral therapy (cART) and metabolic syndrome are associated to an increased cardiovascular risk (CVR). Cystatin C, a low molecular weight cysteine protease inhibitor involved in vascular extracellular matrix remodelling, is considered a novel marker of kidney function and CVR in general population. To value the role of cystatin C in HIV infected patients without chronic kidney disease treated with cART subdivided for CVR.

Methods

56 Caucasian HIV+ cART treated patients without chronic kidney disease were subdivided by means of Framingham score into two groups: A) 15 patients with "high" CVR, and B) 41 patients with "low" CVR. Viro-immunological parameters, triglycerides (TGs), total cholesterol (TCh), HDL (HDL-C) and LDL (LDL-C) cholesterol, blood pressure, microalbuminuria, GFR-MDRD, fasting glucose, insulinemia, HOMA-IR, CRP, cystatin C, IL-18, IL-6, body mass index (BMI) and waist-to-hip ratio (WHR) were measured.

Results

The two groups were homogeneous for years of cART, CD4- and CD8- T cell count, viral load. Group A showed statistically higher levels of BMI (p < 0.009), WHR (p < 0.001), TCh (p < 0.001), LDL-C (p < 0.001), TGs (p < 0.02), systolic blood pressure (p < 0.001), fasting glucose (p < 0.002), insulinemia (p < 0.008), HOMA-IR (p < 0.001), cystatin C (p < 0.001), microalbuminuria (p < 0.001), IL-6 (p < 0.03) and IL-18 (p < 0.01). The GFR-MDRD and the inflammatory index CRP did not show significant differences between the two groups. Finally, data showed a positive correlation between CVR and cystatin C (r = 0.39 and p = 0.003).

Discussion

In the present study it is remarkable that patients in "high" CVR group showed higher values of cystatin C and microalbuminuria even though kidney function was normal. Also microalbuminuria, besides its relation with progressive renal damage, has been found to be an independent factor of CVR and mortality in the general population. Furthermore, the positive correlation between CVR and cystatin C found in this study for the first time in HIV positive patients, is in accord with the evidence existing in literature of a strong association between cystatin C and CVR in the general population. These findings may indicate that cystatin C and microalbuminuria could serve as early markers of enhanced CVR, besides of renal complications, in the HIV-infected population.

Author information

Affiliations

  1. Infectious Disease Clinic, Department of Medicine and Science of Aging, G. d'Annunzio University, Chieti, Italy

    Katia Falasca, Claudio Ucciferri, Paola Mancino, Francesca Vignale & Jacopo Vecchiet

Authors
  1. Katia Falasca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudio Ucciferri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paola Mancino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesca Vignale
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jacopo Vecchiet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Ucciferri.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Falasca, K., Ucciferri, C., Mancino, P. et al. Cystatin C and cardiovascular risk in HIV infected patients. Retrovirology 7, P62 (2010). https://doi.org/10.1186/1742-4690-7-S1-P62

Download citation

Keywords

  • Cholesterol
  • Chronic Kidney Disease
  • Kidney Function
  • Fasting Glucose
  • Cysteine Protease

Retrovirology

ISSN: 1742-4690

Contact us